FCER2 and B-cell chronic lymphocytic leukemia: To the best of our knowledge, this study demonstrated the diagnostic value of a combination of CD43 and CD180 with CD200, FMC7, and CD79b in CD5 negative or CD23 negative CLL for the first time.